MRIdian® MRI-Guided Radiation Therapy Shows Positive Results in Treatment of Ultracentral/Central Lung Tumors

Moffitt researchers conducted a study using MRI-guided SBRT/ hypofractionated radiation therapy with image-guided real-time tracking and automatic...

Age is Just a Number When it Comes to Hematopoietic Cell Transplantation for Myelodysplastic Syndromes

Moffitt Cancer Center has the largest and most active blood and marrow transplant program of its kind in Florida and the Southeast

Improving Brain Metastases Outcomes Through Stereotactic Radiosurgery and Immunotherapies

Stereotactic radiosurgery has been a mainstay of treatment for brain metastases and recent advances in targeted therapies and immunotherapies have...

Age-Related Disparity in Treatment Outcome Among Patients with Metastatic Colorectal Cancer

Dr. Hao Xie, MD, an associate member of the Department of Gastrointestinal Oncology, presents his research on age-related health disparities in young...

New Non-Small Cell Lung Cancer Biomarkers Found

New non-small cell lung cancer biomarker: Distinct ecologies exist between disease that does and does not progress.

Neoadjuvant Therapy Proves Effective in Muscle Invasive Bladder Cancer

Erma Wilson Muldrow, a patient at Moffitt, is thankful after she was enrolled in a phase 1 study involving neoadjuvant therapy to treat bladder...

Minimally Invasive Surgery Advancements for Spinal Tumor Surgery

The Minimally Invasive Spine Oncology (MISO) program is patient-centered with a focus on the use of minimal access techniques for the treatment of...

Methylthioadenosine Phosphorylase (MTAP) Pathway for Genitourinary Cancers

There are several options currently available for the initial treatment of prostate, bladder, and kidney cancer. However, there’re limited resources...

Radiation Oncologist Relates to Cancer Patients 'More Than They Know'

Dr. Roberto Diaz was the section head for Breast Oncology in the Department of Radiation Oncology when he was diagnosed with kidney cancer.

FDA Approves Targeted Radioligand Therapy for Treatment of Advanced Prostate Cancer

The FDA approval of Pluvicto™ is welcome news and an important medical advancement for patients with progressing metastatic castration-resistant...

Engaging the Community Against Cancer

To close the disparity gap in health care, it is critical that medical centers and community organizations work collaboratively to ensure that...

Working to Overcome Health Disparities

At Moffitt Cancer Center we are dedicated to prioritizing the needs of the community we serve, and emphasizing the importance of screening, early...

Sarcoma is Not a Single Disease, There are Actually More Than 70 Subtypes

Sarcoma is a relatively rare type of cancer, accounting for only about 1% of all malignancies in the U.S. Learn more about the types of sarcoma here.

Second-Line Therapy for Large B-Cell Lymphoma

In a recent article published in The New England Journal of Medicine hematologist Dr. Fred Locke at Moffitt Cancer Center details this international,...